Elsevier expands Open Access options for Cell Press Journals from January 2021

LONDON, Dec. 18, 2020  /PRNewswire/ -- Elsevier, a global leader in research publishing and information analytics, today announced that the Cell Press portfolio of journals will be expanding open access publishing options for authors from January 1, 2021.

Open access is an integral part of Elsevier's commitment to a more collaborative, inclusive and transparent world of research where authors, researchers, and academic institutions, can share knowledge and build on each other's work to advance outcomes. We recognise that authors around the world have diverse needs and preferences, so we have been working collaboratively with the communities that we serve to test and learn from different ways of accelerating open access. As one of the fastest-growing open access publishers in the world, nearly all of Elsevier's 2,600 journals now enable open access publishing, including 500 fully open access journals.

From January 2021, all authors will have the option to publish open access across the entire range of the highly regarded and influential Cell Press family of journals. This publishing route means all Cell Press authors can choose to make their research article available for everyone to read immediately following publication.